Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) and BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) Experiencing Unusual Activity Mid-day

Shares of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) are experiencing unusual volume during today’s trading.  While the stock price moved along with the volume change, shares are touching $1.81 at the time of writing.  The day’s total volume of 2556381 this morning is in contrast from the three-month daily average of 438.51K.  When we divide the current volume by the three-month average volume, we get a relative volume of 6.83.

Why is this important?

Trading volume is a hugely important consideration for any investor.  By watching how many shares are trading hands and looking for any changes in that activity, trading opportunities can be spotted along with a deeper understanding of the reliability of other indicators on the stock. 

Looking Back

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)‘s market cap, the total dollar value of all of their outstanding shares, is 21.30m.  Including today’s unusual volume, Cyclacel Pharmaceuticals, Inc.‘s stock is performing at -64.46% on the year.  For the week, the stock is performing 14.29%.  Over the past month the firm’s stock is 11.24%, -56.68% for the last quarter, -53.12% for the past six-months and -62.99% for the last year.

Current levels places Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s stock about -53.35% from the 50-day high and 15.85% away from the 50-day low.  

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) stock is experiencing unusual volume during today’s trading.  While the stock price moved along with the volume change, shares are touching $7.58.  The day’s total volume of 432653 this morning is in contrast from the three-month daily average of 30.42K.  When we divide the current volume by the three-month average volume, we get a relative volume of 16.66.

Looking Back

BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)‘s market cap, the total dollar value of all of their outstanding shares, is 1197.90m.  Including today’s unusual volume, BiondVax Pharmaceuticals Ltd.‘s stock is performing at 99.10% on the year.  For the week, the stock is performing -19.15%.  Over the past month the firm’s stock is -18.06%, -13.56% for the last quarter, 20.40% for the past six-months and 81.75% for the last year.

Current levels places BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)’s stock about -29.49% from the 50-day high and 16.44% away from the 50-day low.  

Leave a Comment